FFAR2 and inflammatory bowel disease: Researchers have revealed that GPR43 could bind with short-chain fatty acids (SCFAs) to regulate the inflammatory responses in intestinal diseases, which indicated that GPCRs took a critical part in the pathogenesis of IBD.